WallStreetZenWallStreetZen

NASDAQ: BTMD
Biote Corp Stock

Overview
ForecastEarningsDividendOwnership
$5.54+0.10 (+1.84%)
Updated Apr 19, 2024
BTMD Price
$5.54
Fair Value Price
N/A
Market Cap
$412.90M
52 Week Low
$3.65
52 Week High
$8.22
P/E
42.62x
P/B
-14.05x
P/S
0.69x
PEG
0.3x
Dividend Yield
N/A
Revenue
$185.36M
Earnings
$3.32M
Gross Margin
68.8%
Operating Margin
6.67%
Profit Margin
1.8%
Debt to Equity
-6.53
Operating Cash Flow
$27M
Beta
0.08
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A

BTMD Overview

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

Zen Score

–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BTMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BTMD ($5.54) is trading below its intrinsic value of $7.11, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BTMD is poor value based on its earnings relative to its share price (42.62x), compared to the US market average (40.51x)
P/E vs Market Valuation
BTMD is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more BTMD due diligence checks available for Premium users.

Be the first to know about important BTMD news, forecast changes, insider trades & much more!

BTMD News

Valuation

BTMD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
42.62x
Industry
-2.45x
Market
40.51x
BTMD is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BTMD is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

BTMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-14.05x
Industry
4.44x

BTMD price to earnings growth (PEG)

For valuing profitable companies with growth potential
BTMD is good value based... subscribe to Premium to read more.
PEG Value Valuation

BTMD's financial health

Profit margin

Revenue
$45.7M
Net Income
$7.7M
Profit Margin
16.9%
BTMD's Earnings (EBIT) of $12.36M... subscribe to Premium to read more.
Interest Coverage Financials
BTMD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$155.3M
Liabilities
$191.8M
Debt to equity
-6.53
BTMD's short-term assets ($122.34M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BTMD's long-term liabilities ($169.63M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BTMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BTMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$7.0M
Investing
$19.0M
Financing
-$2.5M
BTMD's operating cash flow ($26.88M)... subscribe to Premium to read more.
Debt Coverage Financials

BTMD vs Medical Care Facility Stocks

TickerMarket Cap1d %P/EP/B
BTMD$412.90M+1.84%42.62x-14.05x
CYH$391.07M+2.88%-2.80x-0.28x
SNDA$388.47M-0.64%-7.64x-3.38x
AVAH$440.55M+6.02%-3.23x-3.40x
DCGO$371.89M+4.39%51.00x1.24x
View Top Medical Care Facility Stocks

Biote Stock FAQ

What is Biote's quote symbol?

(NASDAQ: BTMD) Biote trades on the NASDAQ under the ticker symbol BTMD. Biote stock quotes can also be displayed as NASDAQ: BTMD.

If you're new to stock investing, here's how to buy Biote stock.

What is the 52 week high and low for Biote (NASDAQ: BTMD)?

(NASDAQ: BTMD) Biote's 52-week high was $8.22, and its 52-week low was $3.65. It is currently -32.6% from its 52-week high and 51.61% from its 52-week low.

How much is Biote stock worth today?

(NASDAQ: BTMD) Biote currently has 74,531,558 outstanding shares. With Biote stock trading at $5.54 per share, the total value of Biote stock (market capitalization) is $412.90M.

Biote stock was originally listed at a price of $10.00 in Mar 2, 2021. If you had invested in Biote stock at $10.00, your return over the last 3 years would have been -44.6%, for an annualized return of -17.87% (not including any dividends or dividend reinvestments).

How much is Biote's stock price per share?

(NASDAQ: BTMD) Biote stock price per share is $5.54 today (as of Apr 19, 2024).

What is Biote's Market Cap?

(NASDAQ: BTMD) Biote's market cap is $412.90M, as of Apr 20, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Biote's market cap is calculated by multiplying BTMD's current stock price of $5.54 by BTMD's total outstanding shares of 74,531,558.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.